Innovations in cancer: novel therapeutics, new diagnostics and future r&d strategies–aarkstore enterprise

Innovations in Cancer: Novel therapeutics, new diagnostics and future R&D strategies–Aarkstore Enterprise

Aarkstore announce a new report  “Innovations in Cancer: Novel therapeutics, new diagnostics and future R&D strategies” through its vast collection of market research report.

The cancer market is highly dynamic, creating a new age of discovery and innovation driven by molecular biology, oncogenomics and new methods in cell biology. These innovations will result in high value opportunities to develop newer and more effective therapies, ensuring companies can effectively respond to the increasing prevalence of cancer.

Innovations in Cancer provides a detailed insight into the evolution of the cancer market, the drivers and resistors of innovation and in-depth analysis of advances in both cancer therapeutics and diagnostics to provide a complete picture of how the cancer market will develop over the next five years. It also identifies key alliance and partnering opportunities highlighting companies with specialised capabilities in the discovery and the characterization of next-generation drug targets.

Use this report to understand how the cancer market is developing, identify areas of unmet medical need and align your product pipeline to achieve clinical and commercial success.

Key findings of the report…

  • In 2000, cancer was responsible for 12% of the 56m deaths world wide. In the same year, 5.3m men and 4.7m women developed a malignant tumor. The World Health Organisation predicts a rise in cancer incidence by 50% by the year 2020, largely due to lifestyle factors.

  • Roche, Sanofi-Aventis and Amgen were the leading players in the cancer market in 2005, generating sales of $8.5bn, $3.9bn and $3.8bn respectively.

  • Unmet patient need is the major driver of innovation in both cancer therapeutics and diagnostics. There is significant need for high-sensitivity diagnostic methods to detect the presence of early-stage disease.

  • Small interfering RNAs are emerging as potential innovative cancer therapies. Whilst the delivery of these molecules remains limited, the number of candidates in development is increasing, with over 25 cancer vaccines in the pipeline.

  • Competitive pressures and reimbursement issues will increase the demand for better evidential information on efficacy and the need for a diagnostic component to the clinical decision-making process.

Key questions answered in this report

  • What are the key unmet needs in the cancer market?

  • How are reimbursement issues affecting innovation in the cancer market?

  • Who are the leading innovators in the global cancer market?

  • Why are theranostic considerations becoming increasingly important in the cancer field?

  • How will scientific advances drive new opportunities in the cancer market in the next 5 years?

  • What will be the leading innovative cancer drugs and diagnostics in the next 5 years?

  • What impact will cancer stems cells, siRNA’s and vaccines have on drug development to 2011?

Top five reasons to order your copy today

  • Gain a detailed insight into the evolution of the cancer market, the drivers and resistors of innovation and how this will influence the development of future strategies.

  • Identify the greatest areas of unmet medical need in the cancer field and how this continues to drive innovation, enabling you to anticipate future trends in the market.

  • Assess your organisation’s position in the market-place, identify competitive innovations and understand how companies are developing better drugs and diagnostics which will displace today’s technologies.

  • Discover the products that are being developed by the leading companies in the cancer market across the ‘top four’ cancers including breast, colorectal, lung and prostate.

  • Understand how the use of oncogenomics will allow for better targeting of cancer, creating opportunities for the development of newer more effective products.

    For more information, please visit :
    http://www.aarkstore.com/reports/Innovations-in-Cancer-Novel-therapeutics-new-diagnostics-and-future-R-D-strategies-34837.html
    Or email us at press@aarkstore.com or call +919272852585

    Special offer till 31th Dec 2009

  • Добавить ВКонтакте заметку об этой странице
  • Мой Мир
  • Facebook
  • Twitter
  • LiveJournal
  • MySpace
  • FriendFeed
  • В закладки Google
  • Google Buzz
  • Яндекс.Закладки
  • LinkedIn
  • Reddit
  • StumbleUpon
  • Technorati
  • del.icio.us
  • Digg
  • БобрДобр
  • MisterWong.RU
  • Memori.ru
  • МоёМесто.ru
  • Сто закладок

Comments are closed.

July 2017
M T W T F S S
« May    
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Recent Posts